AXSM insider sale via cashless exercise disclosed

Axsome Therapeutics insider transaction disclosure: The filing notifies a proposed sale of Class A Common shares tied to a cashless exercise / same-day sale following a stock option acquisition on 05/04/2026.

Rhea-AI Filing Summary

Axsome Therapeutics insider transaction disclosure: The filing notifies a proposed sale of Class A Common shares tied to a cashless exercise / same-day sale following a stock option acquisition on 05/04/2026. The filing also lists two prior sales by Mark Jacobson on 02/26/2026 of 15,378 shares for $2,505,062.36 and 20,000 shares for $3,221,848. The planned method is described as a cashless exercise with same-day sale; timing and exact number of shares proposed for sale on 05/04/2026 are not specified in this excerpt.

Key Figures

Prior sale: 15,378 shares Proceeds from prior sale: $2,505,062.36 Prior sale: 20,000 shares +2 more

5 metrics

Prior sale 15,378 shares sale dated 02/26/2026

Proceeds from prior sale $2,505,062.36 associated with 15,378 shares on 02/26/2026

Prior sale 20,000 shares sale dated 02/26/2026

Proceeds from prior sale $3,221,848 associated with 20,000 shares on 02/26/2026

Option acquisition date 05/04/2026 acquired as compensation — Stock Options

Key Terms

cashless exercise / same-day sale, Form 144/A, acquired as compensation -- Stock Options

3 terms

cashless exercise / same-day sale financial

"Compensation -- Cashless exercise / same-day sale"

Form 144/A regulatory

"144/A: Filer Information"

acquired as compensation -- Stock Options financial

"Acquired as compensation -- Stock Options"

FAQ

What does Axsome (AXSM) Form 144/A disclose about the planned sale?

It discloses a proposed sale of Class A Common shares tied to a cashless exercise / same-day sale after an option acquisition on 05/04/2026. The filing lists prior sales but does not state the proposed share count for 05/04/2026.

How many shares did Mark Jacobson sell in recent transactions listed in the filing?

The filing shows two sales on 02/26/2026: 15,378 shares and 20,000 shares. The corresponding gross amounts reported are $2,505,062.36 and $3,221,848, respectively.

What is a cashless exercise / same-day sale as noted in AXSM's filing?

A cashless exercise / same-day sale means options are exercised and enough resulting shares are immediately sold to cover exercise costs and taxes. The filing describes that method but does not quantify the specific shares to be sold on 05/04/2026.

Does the Form 144/A state who receives proceeds from these transactions?

The excerpt attributes the 05/04/2026 transaction to the issuer and labels the acquisition as compensation. It does not specify the recipient of proceeds for the prior 02/26/2026 sales in this excerpt.

Are the prior sales in February 2026 reflected as completed transactions?

Yes. The filing lists prior sales by Mark Jacobson on 02/26/2026 of 15,378 and 20,000 shares with dollar amounts reported, indicating completed dispositions during the past three months.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/05/2026 - 05:54 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK	0001805812
Filer CCC	XXXXXXXX
Previous Accession Number Of The Filing	0001958244-26-000251
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer	Axsome Therapeutics, Inc.
SEC File Number	001-37635
Address of Issuer	One World Trade Center 29th Floor New York NEW YORK 10007
Phone	1-212-332-3241
Name of Person for Whose Account the Securities are To Be Sold	Mark Jacobson
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	4517	1010452.9	51439952	05/04/2026	NASD

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	05/04/2026	Acquired as compensation -- Stock Options	Issuer			4517	05/04/2026	Compensation -- Cashless exercise / same-day sale

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mark Jacobson One World Trade Center 29th Floor New York NY 10007	Class A Common	02/26/2026	15378	2505062.36
Mark Jacobson One World Trade Center 29th Floor New York NY 10007	Class A Common	02/26/2026	20000	3221848

144/A: Remarks and Signature

Remarks	Amendment to the Form 144 filed on May 4, 2026, which inadvertently omitted the Date of Plan Adoption.
Date of Notice	05/05/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Goldman Sachs & Co. LLC on behalf of Mark Jacobson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)